Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Majedie Inv. Share Price
  4. Majedie Inv. Share Regulatory News
  5. Final Net Asset Value

Pin to quick picksMajedie Inv. Regulatory News (MAJE)

Majedie Inv. Information

Share Price Information for Majedie Inv. (MAJE)

Share Price is delayed by 15 minutes
Get Live Data
308.00    0.00 (0.00%)
Bid:
295.00
Ask:
308.00
Spread: 13.00 (4.407%)
Market Cap: £163.24m
MAJE Live PriceLast checked at - London Stock Exchange

Intraday Majedie Inv. Share Chart

Final Net Asset Value

25 Mar 2025 15:52

RNS Number : 1159C
Majedie Investments PLC
25 March 2025
 

 

 

Majedie Investments PLC

 

Legal Entity Identifier: 2138007QEY9DYONC2723

 

25 March 2025

 

Final Net Asset Value (NAV)

 

The unaudited final net asset value per share at the close of business on 28 February 2025 was as follows:

 

With debentures at par value: 280.84 per share

 

With debentures at fair value: 280.85 per share

 

The net asset value published is on a cum-income basis, ex the Q1 2025 interim dividend of 2.10p per share, and is calculated on 52,998,795 ordinary shares, being the number of shares in issue.

 

The fair value of the March 2025 debenture is calculated by using the yield of UK Treasury Bonds of an equal duration plus a 2.5% risk premium. The Board sees this mechanism as transparent, market related and consistent with best practice.

 

 

 

Enquiries

Juniper Partners

Company Secretary

Ph: 0131 378 0500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVDZGZFKKRGKZM
12345678910
Date   Source Headline
1st Jun 202610:15 amRNSTotal Voting Rights
28th May 20267:00 amRNSHalf-year Financial Report
26th May 20263:04 pmRNSMid-Month Estimated Net Asset Value (NAV)
26th May 20263:02 pmRNSFinal Net Asset Value (NAV)
11th May 20263:45 pmRNSInvestor Event
11th May 20261:25 pmRNSEstimated Net Asset Value
1st May 202610:57 amRNSTotal Voting Rights
29th Apr 202610:00 amRNSDividend Declaration
29th Apr 20269:50 amRNSDirector Declaration
27th Apr 20263:56 pmRNSMid-Month Estimated Net Asset Value
27th Apr 20263:55 pmRNSFinal Net Asset Value
13th Apr 20263:47 pmRNSEstimated Net Asset Value
1st Apr 20268:49 amRNSTotal Voting Rights
25th Mar 20262:46 pmRNSMid-Month Estimated Net Asset Value
25th Mar 20262:41 pmRNSFinal Net Asset Value
10th Mar 20263:06 pmRNSEstimated Net Asset Value (NAV)
2nd Mar 20269:25 amRNSTotal Voting Rights
25th Feb 20263:56 pmRNSMid-Month Estimated Net Asset Value
25th Feb 20263:55 pmRNSFinal Net Asset Value
18th Feb 20264:26 pmRNSResult of AGM
10th Feb 20264:57 pmRNSEstimated Net Asset Value (NAV)
2nd Feb 20269:54 amRNSTotal Voting Rights
29th Jan 20267:00 amRNSDividend Declaration
26th Jan 20264:33 pmRNSMid-Month Estimated Net Asset Value
26th Jan 20264:31 pmRNSFinal Net Asset Value
12th Jan 20265:29 pmRNSEstimated Net Asset Value
2nd Jan 20269:36 amRNSTotal Voting Rights
23rd Dec 20251:30 pmRNSMid-Month Estimated Net Asset Value
23rd Dec 20251:27 pmRNSFinal Net Asset Value
22nd Dec 20257:00 amRNSAnnual Financial Report
22nd Dec 20257:00 amRNSAnnual Financial Report
16th Dec 20254:11 pmRNSBlock listing Interim Review
10th Dec 20253:37 pmRNSEstimated Net Asset Value
1st Dec 202510:13 amRNSTotal Voting Rights
25th Nov 20253:50 pmRNSMid-Month Estimated Net Asset Value
25th Nov 20253:48 pmRNSFinal Net Asset Value
21st Nov 20255:09 pmRNSDirector/PDMR Shareholding
12th Nov 20257:00 amRNSFurther re Marylebone Partners and Brown Advisory
10th Nov 20253:12 pmRNSEstimated Net Asset Value
3rd Nov 202511:28 amRNSTotal Voting Rights
31st Oct 20257:00 amRNS-RKepler Trust Intelligence: New Research
30th Oct 20257:00 amRNSDividend Declaration
24th Oct 20252:34 pmRNSMid-Month Estimated Net Asset Value
24th Oct 20252:29 pmRNSFinal Net Asset Value
24th Oct 202511:44 amRNSDirector/PDMR Shareholding
24th Oct 202511:41 amRNSDirector/PDMR Shareholding
10th Oct 20253:46 pmRNSEstimated Net Asset Value
1st Oct 20259:35 amRNSTotal Voting Rights
25th Sep 20253:32 pmRNSMid-Month Estimated Net Asset Value
25th Sep 20253:31 pmRNSFinal Net Asset Value
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
VTY
Vistry Grp
LSE
2.80%
PNA
PNA.L
LSE
0.00%
SHIP
Tufton Assets.
LSE
0.00%
JESC
JESC.L
LSE
0.00%
NETD
NETD.L
LSE
0.00%
Trending
HE1
Helium One
LSE
6.28%
MAC
Marechale Cap.
LSE
32.88%
IMM
Immupharma
LSE
-5.22%
NEO
Neo Energy Metals
LSE
-10.11%
BSFA
Bio-Sustainable Future Enterprises
LSE
0.00%